Gynaecologic oncology services include the following
Management of abnormal Pap smears or HPV testing
A Pap smear, or cervical cytology, is a diagnostic procedure to analyse precancerous cervical cellular changes, or to check for Human Papillomavirus (HPV) infection. The procedure involves removing cervical or vaginal cells with a small brush to check for HPV infection or significant abnormal changes, which may result in genital warts, precancers and cancer.
Enquiries about the HPV vaccination
HPV vaccines are safe and can be administered from the age of nine. It is advised that all young men and women receive the HPV vaccine so they are safeguarded from HPV infections that may result in genital warts and cancer much later in life.
Diagnosis of all gynaecological cancers
The diagnosis of gynaecological cancers involves a thorough review of the patient’s full medical history, a comprehensive physical exam and several diagnostic tests.
Management and follow-up of all gynaecological cancers
Individualised treatment for all cancers of the female reproductive tract. Continued management and follow-ups are strictly advised, in order to identify cancer recurrence or any new issues as soon as possible.
Management of gestational trophoblastic disease (GTD) and gestational trophoblastic neoplasia (GTN)
GTD is a name provided for a rare collection of abnormal tumours that occur during the initial stages of pregnancy and if they persist and spread, are classified as GTN. The treatment of gestational trophoblastic disease might involve either, or a combination of, uterine evacuation and surgery. Chemotherapy is also widely used for gestational trophoblastic neoplasia.
Screening and surveillance for female cancers
There are multiple screening options for gynaecological and other cancers, such as:
- Pap Smear: A highly recommended test designed to check for abnormal changes of cervical cells or high risk HPV infection, to prevent cervical cancer.
- Endometrial tissue sampling: This form of sampling is done to check for suspicious/abnormal cells of the endometrium (inside lining of the womb). It is recommended for women at an increased risk of endometrial cancer.
- Mammogram: Screening mammograms to assess for breast cancer is recommended from 40 years of age.
FREQUENTLY ASKED QUESTIONS